Conclusion: my own opinion I'm more excited than ever about @GenomesDAO ! The team remains focused on building the best product and I love that. Incredible things are coming en 2024 🤩 I really glad to be part of it and to spread the vision and the project. Follow me of you…

5/ Will there be marketing from

t.co

to make people aware of the benefits of DeSci so more people use the services ? Yes, the team will doing marketing. But like any other successfully project in the Web3 sphere: Community has to help. It’s our task to relay…

3/ What about listings of $GENE token? It will be request at the good time, when the product of @GenomesDAO will be advanced enough to make the listing on a an exchange like Binance or other an evidence. Stay focus on the product.

4/ What makes you different from your competitors? Basically, @GenomesDAO doesn’t want to be a research lab but an infrastructure that making sure the genomic market is fair and transparent 🤝 The team wants to improve research and work with researchers but not to be the…

2/ Where do you see @GenomesDAO in 5 years ? @GenomesDAO is today the largest user owned genomic database in the world. In 5 years, @aldodepape expect it 200 times bigger (minimum). His vision is that people continue to own their genomic data and use them in the DAO as an…

👉 Creation of an API: According to me, that's one of the most exciting feature in the pipe! The team develops an API to plug to @GenomesDAO any other app that need to read genomic data for any purpose. The plugged app could make query and users could accept or not and be…

3️⃣ FAQ 1/ How @GenomesDAO will create more utility and value for token $GENE and holders? In few words : by investing more and more to build a strong DAO and a strong community. @aldodepape repeated that his team stay fully focused to deliver the best working product as…

2️⃣ Roadmap for 2024 🤩 Following the the wise words of @brian_armstrong , @aldodepape said the focus of all team members of @GenomesDAO for 2024 is: "To deliver a working product so rich to let no reason any pharmaceutical companies, research organizations or any organization…

Basically here are the next steps: 👉 Development of virtual laboratories Virtual labs is a feature that allow researchers to create a dedicated board on @GenomesDAO to work on specific disease, and use specific data. 👉 Development of reports: The team works to improve and…

👉 Summit in Taipei, Taiwan in December 2023: @brian_armstrong highlighted the most important thing in DeSci: → You need to have a working product to succeed. DeSci cannot only be a promise and a launching of a token. Actually it’s the case with @GenomesDAO . → It is a…

👉 Summit in Doha, Qatar in november 2023: @Aldodepape spoke about how AI could serve @GenomesDAO , essentially for the interpretation of vaults and research informations, in a manner to improve and scale the process. The team forecasts to grow 10 000 vaults in 2024 and many…

After this success, many organizations came to @GenomesDAO to be part of the journey and query surveys on the infrastructure to advance their researches about rare diseases and cancers. Conversations are also engaged with some pharmaceutical and genetic companies. More and more…

This proves 2 things: 1/ The financial incentive is working for users, and the genomic data shared are helpful for researchers. So the service delivered by @GenomesDAO is relevant for both. 2/ The infrastructure is working and secure: the product follows the promise.…

1️⃣ Hindsights of 2023 👉 Launching the Infrastructure of Vaults: The infrastructure of @GenomesDAO was successfully activated by the integration of an AMD software. This is a proprietary software built with AMD technology specifically for genomic activities and owned by the…

👉 Success of the first query: The first auditable, anonymously executed and financially incentivized query succeeded on GenomesDAO in August 2023 👏 It was a survey destined to determine if holders of vaults were susceptible to contract a long form of Covid 🦠 More than 75%…